$LUMO
Lumos Pharma Inc Stock $lumo

$lumo Overview Financials Valuation SEC Filings Company Website

2013 Form 10-K Financial Statement

#000112623414000080 Filed on March 12, 2014

Income Statement

Concept	2013	2012 Q4	2012 Q3
Revenue	$1.093M	$299.0K	$327.0K
YoY Change	-35.21%	-0.66%	-23.95%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$9.500M	$2.100M	$1.400M
YoY Change	33.8%	0.0%	27.27%
% of Gross Profit
Research & Development	$22.71M	$4.500M	$4.779M
YoY Change	27.33%	12.5%	44.77%
% of Gross Profit
Depreciation & Amortization	$900.0K	$200.0K	$200.0K
YoY Change	12.5%	0.0%	0.0%
% of Gross Profit
Operating Expenses	$32.23M	$6.600M	$6.175M
YoY Change	29.22%	8.2%	40.28%
Operating Profit	-$31.14M	-$6.293M	-$5.848M
YoY Change	33.89%	8.43%	47.23%
Interest Expense	$0.00	$0.00	$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	$91.00K	$0.00	-$3.000K
YoY Change	-246.77%		-78.57%
Pretax Income	-$31.05M	-$6.300M	-$5.900M
YoY Change	33.14%	8.62%	47.5%
Income Tax	$130.0K	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$31.18M	-$6.319M	-$5.851M
YoY Change	33.7%	8.76%	46.79%
Net Earnings / Revenue	-2852.7%	-2113.38%	-1789.3%
Basic Earnings Per Share	-$1.23	-$0.30	-$0.28
Diluted Earnings Per Share	-$1.23	-$2.739M	-$0.28
COMMON SHARES
Basic Shares Outstanding	25.28M shares	20.92M shares	20.89M shares
Diluted Shares Outstanding	25.28M shares		20.89M shares

Balance Sheet

Concept	2013	2012 Q4	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$61.50M	$21.70M	$28.30M
YoY Change	183.41%	-48.33%	349.21%
Cash & Equivalents	$61.30M	$20.25M	$25.56M
Short-Term Investments	$200.0K	$1.500M	$2.700M
Other Short-Term Assets	$800.0K	$900.0K	$100.0K
YoY Change	-11.11%	125.0%	-95.0%
Inventory
Prepaid Expenses		$907.0K	$145.0K
Receivables
Other Receivables
Total Short-Term Assets	$64.00M	$23.39M	$28.92M
YoY Change	173.5%	-45.34%	224.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.600M	$6.040M	$6.087M
YoY Change	10.0%	8.03%	19.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$6.600M	$6.040M	$6.087M
YoY Change	10.0%	8.03%	19.35%
TOTAL ASSETS
Total Short-Term Assets	$64.00M	$23.39M	$28.92M
Total Long-Term Assets	$6.600M	$6.040M	$6.087M
Total Assets	$70.60M	$29.43M	$35.01M
YoY Change	140.14%	-39.17%	150.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$600.0K	$972.0K	$708.0K
YoY Change	-40.0%	-41.8%	136.0%
Accrued Expenses	$2.900M	$1.659M	$2.136M
YoY Change	70.59%	-11.14%	25.65%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$200.0K	$149.0K	$148.0K
YoY Change	0.0%	60.22%	-97.61%
Total Short-Term Liabilities	$3.900M	$2.919M	$3.150M
YoY Change	34.48%	-72.63%	-65.38%
LONG-TERM LIABILITIES
Long-Term Debt	$1.000M	$1.178M	$7.200M
YoY Change	-16.67%	30.89%	620.0%
Other Long-Term Liabilities	$7.300M	$7.400M	$1.400M
YoY Change	-1.35%
Total Long-Term Liabilities	$8.300M	$8.583M	$8.635M
YoY Change	-3.49%	811.15%	763.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.900M	$2.919M	$3.150M
Total Long-Term Liabilities	$8.300M	$8.583M	$8.635M
Total Liabilities	$12.20M	$11.50M	$11.79M
YoY Change	6.09%	-0.9%	16.68%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock			$209.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$58.30M	$17.90M	$23.20M
YoY Change
Total Liabilities & Shareholders Equity	$70.60M	$29.43M	$35.01M
YoY Change	140.14%	-39.17%	150.06%

Cashflow Statement

Concept	2013	2012 Q4	2012 Q3
OPERATING ACTIVITIES
Net Income	-$31.18M	-$6.319M	-$5.851M
YoY Change	33.7%	8.76%	46.79%
Depreciation, Depletion And Amortization	$900.0K	$200.0K	$200.0K
YoY Change	12.5%	0.0%	0.0%
Cash From Operating Activities	-$25.80M	-$6.700M	-$3.400M
YoY Change	25.85%	318.75%	0.0%
INVESTING ACTIVITIES
Capital Expenditures	$1.386M	-$200.0K	$0.00
YoY Change	4.76%	0.0%
Acquisitions	$0.00
YoY Change
Other Investing Activities	$1.200M	$1.200M	-$2.000M
YoY Change	20.0%	-148.0%	-766.67%
Cash From Investing Activities	-$141.0K	$1.000M	-$2.000M
YoY Change	-49.1%	-137.04%	-1100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$66.36M
YoY Change	42988.96%
Debt Paid & Issued, Net	$149.0K
YoY Change	39.25%
Cash From Financing Activities	$67.00M	300.0K	600.0K
YoY Change	4342.97%	-99.2%
NET CHANGE
Cash From Operating Activities	-25.80M	-6.700M	-3.400M
Cash From Investing Activities	-$141.0K	1.000M	-2.000M
Cash From Financing Activities	$67.00M	300.0K	600.0K
Net Change In Cash	$66.86M	-5.400M	-4.800M
YoY Change	5331.28%	-116.27%	50.0%
FREE CASH FLOW
Cash From Operating Activities	-$25.80M	-$6.700M	-$3.400M
Capital Expenditures	$1.386M	-$200.0K	$0.00
Free Cash Flow	-$27.19M	-$6.500M	-$3.400M
YoY Change	24.57%	364.29%	0.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	1328000	USD
CY2012Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	196000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	972000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	612000	USD
CY2012Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	130000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1659000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2861000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3858000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2978000	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	122514000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	194038000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4400000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3200000	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2500000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12900000	USD
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3752413	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4486564	shares
CY2013Q4	us-gaap	Assets Assets	70557000	USD
CY2012Q4	us-gaap	Assets Assets	29429000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	23389000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	63970000	USD
CY2011Q1	us-gaap	Business Acquisition Equity Interest Issued Or Issuable Value Assigned BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned	8600000	USD
CY2011	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	481000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2013	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2012	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	53000	USD
CY2013Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	35000	USD
CY2012Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	55000	USD
CY2012Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	38000	USD
CY2013Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	46000	USD
CY2012Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	516000	USD
CY2013Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	570000	USD
CY2013Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	277000	USD
CY2012Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	305000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	86000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	38000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Rolling Year Three CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree	12000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Rolling Year Two CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo	36000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	4000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Net Minimum Payments1 CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1	82000	USD
CY2013Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	293000	USD
CY2012Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	211000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	61291000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39490000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20250000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10572000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	61291000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	41041000	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	28918000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-19240000	USD
CY2012Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	1494000	USD
CY2013Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	249000	USD
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	38833334	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20985192	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26573023	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26573023	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20985192	shares
CY2013Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	266000	USD
CY2012Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	210000	USD
CY2013	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, and certificates of deposit. Cash and cash equivalents are held by financial institutions and are federally insured up to certain limits. At times, the Company’s cash and cash equivalents balance exceeds the federally insured limits. To limit the credit risk, the Company invests its excess cash primarily in high quality securities such as money market funds. </font></div></div>
CY2012	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0	USD
CY2011	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0	USD
CY2013	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0	USD
	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	-449000	USD
CY2012Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	1500000	USD
CY2013Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	1400000	USD
CY2012Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	84000	USD
CY2013Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	84000	USD
CY2013Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1321000	USD
CY2012Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1405000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	295000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	313000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	25168000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	23154000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	17000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	18556000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	19853000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	20000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	120000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	0	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2912000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4322000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	107000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	76000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1748000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	0	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23137000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	25168000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	17000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4640000	USD
CY2012	us-gaap	Depreciation And Amortization DepreciationAndAmortization	788000	USD
CY2011	us-gaap	Depreciation And Amortization DepreciationAndAmortization	687000	USD
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	891000	USD
CY2012Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	104797000	USD
CY2013Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	135977000	USD
CY2012Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0	USD
CY2013Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0	USD
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.98
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.12
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.23
CY2013Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	7000000	USD
CY2012	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2013	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2011	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2013	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	54000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	596000	USD
CY2012	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2011	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	80000	USD
CY2011	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-2269000	USD
CY2013	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-1494000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-13282000	USD
CY2012	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-2988000	USD
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	2000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	40000	USD
CY2011	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2012	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	38000	USD
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5679000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	46464000	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7108000	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9521000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-136390000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-23321000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18088000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-31050000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	130000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	130000	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-700000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-619000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-359000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	637000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	130000	USD
CY2011	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	USD
CY2012	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	USD
CY2013	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	130000	USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1118000	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	367000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4266000	USD
CY2011	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	276000	USD
CY2011	us-gaap	Increase Decrease In Notes Receivable Related Parties IncreaseDecreaseInNotesReceivableRelatedParties	0	USD
	us-gaap	Increase Decrease In Notes Receivable Related Parties IncreaseDecreaseInNotesReceivableRelatedParties	350000	USD
CY2013	us-gaap	Increase Decrease In Notes Receivable Related Parties IncreaseDecreaseInNotesReceivableRelatedParties	0	USD
CY2012	us-gaap	Increase Decrease In Notes Receivable Related Parties IncreaseDecreaseInNotesReceivableRelatedParties	0	USD
CY2013	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1132000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1328000	USD
CY2012	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0	USD
CY2011	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	416000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	550000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-498000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-773000	USD
CY2011	us-gaap	Interest Expense Debt InterestExpenseDebt	42000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	134000	USD
CY2011	us-gaap	Investment Income Interest InvestmentIncomeInterest	11000	USD
CY2012	us-gaap	Investment Income Interest InvestmentIncomeInterest	14000	USD
CY2013	us-gaap	Interest Expense Debt InterestExpenseDebt	33000	USD
CY2012	us-gaap	Interest Expense Debt InterestExpenseDebt	38000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	214000	USD
	us-gaap	Interest Paid InterestPaid	176000	USD
CY2011	us-gaap	Interest Paid InterestPaid	42000	USD
CY2013	us-gaap	Interest Paid InterestPaid	34000	USD
CY2012	us-gaap	Interest Paid InterestPaid	38000	USD
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	12000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1779000	USD
CY2012Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5085000	USD
CY2013Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	5588000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	11502000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	12230000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29429000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	70557000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3876000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2919000	USD
CY2013Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1200000	USD
CY2012Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1400000	USD
CY2013Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8354000	USD
CY2012Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8583000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	154000	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	149000	USD
CY2007	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	8000	USD
CY2008	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	-1000	USD
CY2011	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	-8634000	USD
CY2005	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2278000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	187492000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1508000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	42369000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	67000000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-141000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-277000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10147000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-502000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-12949000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-116054000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	505000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-20471000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-25818000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-23321000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-135937000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-18087000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-31180000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-583000	USD
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2012	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2011	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-23321000	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-31180000	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-18087000	USD
CY2006	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	257000	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	24946000	USD
	us-gaap	Operating Expenses OperatingExpenses	147333000	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	19934000	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	32234000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-138836000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-18062000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-31141000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-23259000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6301000	USD
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-7913000	USD
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-6293000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8117000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8042000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4817000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-7069000	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5848000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1443000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	610000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	34000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	164000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	306000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	329000	USD
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	601000	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	766000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4500000	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	707000	USD
CY2013Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	88400000	USD
CY2013	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	112000	USD
CY2011	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	5000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	432000	USD
CY2012	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	-38000	USD
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4000	USD
CY2012	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2446000	USD
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-26000	USD
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	91000	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-62000	USD
CY2011	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-13000	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	120000	USD
CY2011	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2012	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1992000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	13531000	USD
CY2013	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	249000	USD
CY2011	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2490000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9478000	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	281000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1323000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1386000	USD
CY2006	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	4000	USD
CY2011	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	8000	USD
CY2004	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	5000	USD
CY2005	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	82000	USD
CY2003	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	5000	USD
CY2010	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	2000	USD
CY2002	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	6000	USD
CY2012	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	0	USD
	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	113000	USD
CY2013	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	0	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2012Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	773000	USD
CY2012Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	907000	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	67215000	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1285000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	109660000	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	37574000	USD
CY2009	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	40000	USD
CY2010	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	911000	USD
CY2000	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	989000	USD
CY2013	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	67743000	USD
CY2011	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	5000000	USD
CY2012	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	3479000	USD
CY2012	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2013	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2011	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2012	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	456000	USD
CY2013	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	8215000	USD
CY2011	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2012	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	50000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	50000	USD
CY2011	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2011	us-gaap	Profit Loss ProfitLoss	-18088000	USD
CY2012	us-gaap	Profit Loss ProfitLoss	-23321000	USD
	us-gaap	Profit Loss ProfitLoss	-136520000	USD
CY2013	us-gaap	Profit Loss ProfitLoss	-31180000	USD
CY2008	us-gaap	Profit Loss ProfitLoss	-8842000	USD
CY2007	us-gaap	Profit Loss ProfitLoss	-7582000	USD
CY2006	us-gaap	Profit Loss ProfitLoss	-5318000	USD
CY2004	us-gaap	Profit Loss ProfitLoss	-3669000	USD
CY2005	us-gaap	Profit Loss ProfitLoss	-4770000	USD
CY2003	us-gaap	Profit Loss ProfitLoss	-2979000	USD
CY2010	us-gaap	Profit Loss ProfitLoss	-16562000	USD
CY2009	us-gaap	Profit Loss ProfitLoss	-10207000	USD
CY2002	us-gaap	Profit Loss ProfitLoss	-2253000	USD
CY2000	us-gaap	Profit Loss ProfitLoss	-236000	USD
	us-gaap	Profit Loss ProfitLoss	-64000	USD
CY2001	us-gaap	Profit Loss ProfitLoss	-1448000	USD
CY2012Q4	us-gaap	Profit Loss ProfitLoss	-6319000	USD
CY2013Q2	us-gaap	Profit Loss ProfitLoss	-7077000	USD
CY2012Q1	us-gaap	Profit Loss ProfitLoss	-4842000	USD
CY2013Q4	us-gaap	Profit Loss ProfitLoss	-8046000	USD
CY2013Q3	us-gaap	Profit Loss ProfitLoss	-8123000	USD
CY2012Q2	us-gaap	Profit Loss ProfitLoss	-6309000	USD
CY2013Q1	us-gaap	Profit Loss ProfitLoss	-7934000	USD
CY2012Q3	us-gaap	Profit Loss ProfitLoss	-5851000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	636000	USD
CY2012	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	35000	USD
CY2011	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	22000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1133000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6587000	USD
CY2013	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	59000	USD
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	386000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6040000	USD
CY2012	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	0	USD
CY2013	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	0	USD
CY2011	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	0	USD
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	7000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	475000	USD
CY2012	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	122000	USD
CY2013	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	66000	USD
CY2011	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	126000	USD
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	149000	USD
CY2011	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	92000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	625000	USD
CY2012	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	107000	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22713000	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14255000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	100869000	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17838000	USD
CY2011	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	1629000	USD
CY2013	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2012	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2012	us-gaap	Revenue From Grants RevenueFromGrants	1687000	USD
CY2013	us-gaap	Revenue From Grants RevenueFromGrants	1093000	USD
CY2011	us-gaap	Revenue From Grants RevenueFromGrants	1872000	USD
	us-gaap	Revenue From Grants RevenueFromGrants	8497000	USD
CY2012Q2	us-gaap	Revenue From Grants RevenueFromGrants	590000	USD
CY2013Q1	us-gaap	Revenue From Grants RevenueFromGrants	302000	USD
CY2013Q3	us-gaap	Revenue From Grants RevenueFromGrants	265000	USD
CY2013Q4	us-gaap	Revenue From Grants RevenueFromGrants	294000	USD
CY2012Q4	us-gaap	Revenue From Grants RevenueFromGrants	299000	USD
CY2012Q1	us-gaap	Revenue From Grants RevenueFromGrants	471000	USD
CY2013Q2	us-gaap	Revenue From Grants RevenueFromGrants	232000	USD
CY2012Q3	us-gaap	Revenue From Grants RevenueFromGrants	327000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	3195000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	12909000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	4365000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	2545000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	10.25
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	3000000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	2500000	USD
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	7800000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3193753	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.87
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1600000	USD
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	194000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3600000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	18558	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	860250	shares
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	664323	shares
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	672079	shares
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.12
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.50
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.02
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	72300000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4486564	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3752413	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.89
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.34
	us-gaap	Stock Issued1 StockIssued1	1654000	USD
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.11
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.00
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	12.54
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	57900000	USD
CY2013	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2012	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2011	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	107541	shares
CY2006	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	130000	USD
CY2005	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	354000	USD
CY2010	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	819000	USD
CY2011	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	75390000	USD
CY2010	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	114000	USD
CY2013	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	416000	USD
CY2012	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	239000	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	48916000	USD
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	37555000	USD
CY2010	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2000	USD
CY2009	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3000	USD
CY2001	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	27000	USD
CY2000	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	47000	USD
CY2004	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	57000	USD
CY2003	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	15000	USD
CY2005	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	2000	USD
CY2002	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	14000	USD
CY2006	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	22000	USD
CY2008	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	86000	USD
CY2007	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	58000	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4365000	USD
CY2012	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3195000	USD
CY2011	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2545000	USD
CY2003	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	46000	USD
CY2005	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	51000	USD
CY2009	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	929000	USD
CY2010	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1525000	USD
CY2008	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	19000	USD
CY2007	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12000	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	887000	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	442000	USD
CY2011	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	19000	USD
CY2003	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1112000	USD
CY2009	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	15000	USD
CY2010	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	82000	USD
CY2002	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13000	USD
CY2005Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-10418000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	58327000	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17927000	USD
CY1999Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	0	USD
CY2002Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2836000	USD
CY2008Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-31566000	USD
CY2006Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15331000	USD
CY2007Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-22833000	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	36773000	USD
CY1999Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-37000	USD
CY2009Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-40786000	USD
CY2010Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-52019000	USD
CY2001Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-637000	USD
CY2004Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8252000	USD
CY2003Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4640000	USD
CY2000Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	776000	USD
CY2013Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	4300000	USD
CY2012	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4000	USD
CY2010	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	469000	USD
CY2001	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	15000	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2000000	USD
CY2012	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4300000	USD
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20779450	shares
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6064542	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25275179	shares
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20779450	shares
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6064542	shares
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	25275179	shares
CY2007	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	2000	USD
CY2011	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	13000	USD
CY2003	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	7000	USD
CY2005	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	1000	USD
CY2004	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	5000	USD
CY2010	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	146000	USD
CY2002	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	33000	USD
CY2000	nlnk	Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock	13000	USD
CY2011Q1	nlnk	Book Value Of Net Assets Acquired BookValueOfNetAssetsAcquired	2900000	USD
CY2013Q4	nlnk	Cash And Cash Equivalents Excluding Certificates Of Deposit CashAndCashEquivalentsExcludingCertificatesOfDeposit	61291000	USD
CY2012Q4	nlnk	Cash And Cash Equivalents Excluding Certificates Of Deposit CashAndCashEquivalentsExcludingCertificatesOfDeposit	20250000	USD
CY2013Q4	nlnk	Computerequipmentundercapitallease Computerequipmentundercapitallease	54000	USD
CY2012Q4	nlnk	Computerequipmentundercapitallease Computerequipmentundercapitallease	0	USD
CY2013	nlnk	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition In Years EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognitionInYears	2.7
CY2010	nlnk	Exercise Of Warrants ExerciseOfWarrants	2000000	USD
CY2013	nlnk	Financing Received FinancingReceived	67200000	USD
CY2012	nlnk	Financing Received FinancingReceived	1300000	USD
CY2012	nlnk	Forgiveness Of Notes Receivable From Related Parties ForgivenessOfNotesReceivableFromRelatedParties	0	USD
	nlnk	Forgiveness Of Notes Receivable From Related Parties ForgivenessOfNotesReceivableFromRelatedParties	350000	USD
CY2013	nlnk	Forgiveness Of Notes Receivable From Related Parties ForgivenessOfNotesReceivableFromRelatedParties	0	USD
CY2011	nlnk	Forgiveness Of Notes Receivable From Related Parties ForgivenessOfNotesReceivableFromRelatedParties	0	USD
CY2013	nlnk	Greater Than10 Stockholder Iso Exercise Price Threshold GreaterThan10StockholderIsoExercisePriceThreshold	1.1
CY2013	nlnk	Increase Decrease In State Research And Development Credit Receivable IncreaseDecreaseInStateResearchAndDevelopmentCreditReceivable	213000	USD
	nlnk	Increase Decrease In State Research And Development Credit Receivable IncreaseDecreaseInStateResearchAndDevelopmentCreditReceivable	-329000	USD
CY2011	nlnk	Increase Decrease In State Research And Development Credit Receivable IncreaseDecreaseInStateResearchAndDevelopmentCreditReceivable	28000	USD
CY2012	nlnk	Increase Decrease In State Research And Development Credit Receivable IncreaseDecreaseInStateResearchAndDevelopmentCreditReceivable	-340000	USD
CY2013Q4	nlnk	Intrinsic Value Price Per Share Base IntrinsicValuePricePerShareBase	22.01
CY2013Q4	nlnk	Intrinsic Value Unvested IntrinsicValueUnvested	14400000	USD
CY2013	nlnk	Iowa Refundable Research Credit IowaRefundableResearchCredit	329000	USD
	nlnk	Iowa Refundable Research Credit IowaRefundableResearchCredit	2400000	USD
CY2012	nlnk	Iowa Refundable Research Credit IowaRefundableResearchCredit	283000	USD
CY2011	nlnk	Iowa Refundable Research Credit IowaRefundableResearchCredit	160000	USD
CY2013	nlnk	Iso Stockholder Ownership Threshold IsoStockholderOwnershipThreshold	0.1
CY2013Q4	nlnk	Lab Equipment LabEquipment	3724000	USD
CY2012Q4	nlnk	Lab Equipment LabEquipment	3297000	USD
CY2013Q4	nlnk	Lab Equipment Under Capital Lease LabEquipmentUnderCapitalLease	489000	USD
CY2012Q4	nlnk	Lab Equipment Under Capital Lease LabEquipmentUnderCapitalLease	489000	USD
CY2013Q4	nlnk	Leasehold Improvements Under Capital Lease LeaseholdImprovementsUnderCapitalLease	27000	USD
CY2012Q4	nlnk	Leasehold Improvements Under Capital Lease LeaseholdImprovementsUnderCapitalLease	27000	USD
CY2012	nlnk	Licensing Payments Under All In Licensing Agreements LicensingPaymentsUnderAllInLicensingAgreements	255000	USD
	nlnk	Licensing Payments Under All In Licensing Agreements LicensingPaymentsUnderAllInLicensingAgreements	2900000	USD
CY2013	nlnk	Licensing Payments Under All In Licensing Agreements LicensingPaymentsUnderAllInLicensingAgreements	88000	USD
CY2011	nlnk	Licensing Payments Under All In Licensing Agreements LicensingPaymentsUnderAllInLicensingAgreements	89000	USD
CY2011	nlnk	Noncash Issuance Of Common Stock Dividend To Preferred Shareholders NoncashIssuanceOfCommonStockDividendToPreferredShareholders	1000	USD
CY2013	nlnk	Noncash Issuance Of Common Stock Dividend To Preferred Shareholders NoncashIssuanceOfCommonStockDividendToPreferredShareholders	0	USD
CY2012	nlnk	Noncash Issuance Of Common Stock Dividend To Preferred Shareholders NoncashIssuanceOfCommonStockDividendToPreferredShareholders	0	USD
	nlnk	Noncash Issuance Of Common Stock Dividend To Preferred Shareholders NoncashIssuanceOfCommonStockDividendToPreferredShareholders	6000	USD
CY2011Q1	nlnk	Options Issued In Acquisition OptionsIssuedInAcquisition	50513	shares
CY2011Q4	nlnk	Post Ipo Converted Common Stock PostIpoConvertedCommonStock	10719353	shares
CY2011Q4	nlnk	Pre Ipo Convertible Preferred Stock PreIpoConvertiblePreferredStock	14270113	shares
CY2011Q1	nlnk	Reduction Of Additional Paid In Capital ReductionOfAdditionalPaidInCapital	5700000	USD
CY2012	nlnk	Reduction Of Ipo Offering Costs ReductionOfIpoOfferingCosts	158000	USD
	nlnk	Reduction Of Ipo Offering Costs ReductionOfIpoOfferingCosts	158000	USD
CY2013	nlnk	Reduction Of Ipo Offering Costs ReductionOfIpoOfferingCosts	0	USD
CY2011	nlnk	Reduction Of Ipo Offering Costs ReductionOfIpoOfferingCosts	0	USD
CY2013	nlnk	Reverse Split Denominator ReverseSplitDenominator	1	shares
CY2013	nlnk	Reverse Split Numerator ReverseSplitNumerator	2.1	shares
CY2013Q4	nlnk	Royalty Obligation Payable Noncurrent RoyaltyObligationPayableNoncurrent	6000000	USD
CY2012Q4	nlnk	Royalty Obligation Payable Noncurrent RoyaltyObligationPayableNoncurrent	6000000	USD
CY2011Q1	nlnk	Series E Preferred Issued In Acquisition SeriesEPreferredIssuedInAcquisition	276304	shares
CY2011	nlnk	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateMinimum	0
CY2013	nlnk	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateMinimum	0
CY2010	nlnk	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateMinimum	0
CY2013Q4	nlnk	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Vesting Term In Years ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageVestingTermInYears	6.8
CY2013Q4	nlnk	Share Based Compensation Shares Authorized Under Stock Option Plans Exercisable Options Weighted Average Vesting Term In Years ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisableOptionsWeightedAverageVestingTermInYears	6.1
CY2012Q4	nlnk	State Research And Development Credit Receivable StateResearchAndDevelopmentCreditReceivable	542000	USD
CY2013Q4	nlnk	State Research And Development Credit Receivable StateResearchAndDevelopmentCreditReceivable	329000	USD
CY2008	nlnk	Stock Issued For Licensing StockIssuedForLicensing	5000	USD
CY2010	nlnk	Stock Issued For Licensing StockIssuedForLicensing	201000	USD
CY2013	nlnk	Stockissuedunder Atm StockissuedunderATM	17441000	USD
CY2013	nlnk	Tenant Improvement Allowance TenantImprovementAllowance	622000	USD
CY2012Q4	nlnk	Total Leasehold Improvements And Equipment TotalLeaseholdImprovementsAndEquipment	9018000	USD
CY2013Q4	nlnk	Total Leasehold Improvements And Equipment TotalLeaseholdImprovementsAndEquipment	10445000	USD
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q4
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001126234
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27861429	shares
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013Q2	dei	Entity Public Float EntityPublicFloat	342253457	USD
CY2013	dei	Entity Registrant Name EntityRegistrantName	NEWLINK GENETICS CORP
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No

Files In Submission

Name	View Source	Status
0001126234-14-000080-index-headers.html	Edgar Link	pending
0001126234-14-000080-index.html	Edgar Link	pending
0001126234-14-000080.txt	Edgar Link	pending
0001126234-14-000080-xbrl.zip	Edgar Link	pending
checkptgraphic.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hamechanism.jpg	Edgar Link	pending
image1a03.gif	Edgar Link	pending
image2a03.jpg	Edgar Link	pending
isurplogoa01.jpg	Edgar Link	pending
newlinkpipeline.jpg	Edgar Link	pending
newlogo.jpg	Edgar Link	pending
nlnk-20131231.xml	Edgar Link	completed
nlnk-20131231.xsd	Edgar Link	pending
nlnk-20131231x10k.htm	Edgar Link	pending
nlnk-20131231xex1093.htm	Edgar Link	pending
nlnk-20131231xex1094.htm	Edgar Link	pending
nlnk-20131231xex1095.htm	Edgar Link	pending
nlnk-20131231xex1096.htm	Edgar Link	pending
nlnk-20131231xex211.htm	Edgar Link	pending
nlnk-20131231xex231.htm	Edgar Link	pending
nlnk-20131231xex311.htm	Edgar Link	pending
nlnk-20131231xex312.htm	Edgar Link	pending
nlnk-20131231xex321.htm	Edgar Link	pending
nlnk-20131231_cal.xml	Edgar Link	unprocessable
nlnk-20131231_def.xml	Edgar Link	unprocessable
nlnk-20131231_lab.xml	Edgar Link	unprocessable
nlnk-20131231_pre.xml	Edgar Link	unprocessable
nlnk-201312_chartx49546.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LUMO
Lumos Pharma Inc Stock $lumo

2013 Form 10-K Financial Statement

#000112623414000080 Filed on March 12, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUMO Lumos Pharma Inc Stock $lumo

2013 Form 10-K Financial Statement

#000112623414000080 Filed on March 12, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUMO
Lumos Pharma Inc Stock $lumo